Featured Posts
News Release
FDA commissioner resignation opens opportunity for refocus on science over politics
After a somewhat tumultuous tenure, FDA commissioner Marty Makary is stepping down. While Dr. Makary made his mission to accelerate drug approval and bring a…
Blog
Don’t hinder biosimilar development
In its most recent legislative session, the Florida legislature considered precluding pharmacy benefit managers (PBMs) from holding an investment interest in biosimilar manufacturing. That…
Blog
The unseen costs of banning PBM-owned pharmacies in Tennessee
Tennessee lawmakers recently passed the FAIR Rx Act, which would bar companies from owning pharmacies while also operating a pharmacy benefit manager (PBM) and…
Search Posts
National Review
Covid-19 Treatments and the FDA: A Sense of Urgency Might Help
As the Delta variant surges in various locales and the new Omicron variant expands around the globe, public officials are beginning to reimpose Covid-19…
National Review
The Covid Mandates Should Be Ignored
the highways in South Florida, the speed limit is generally 55 mph. I don’t know why, but it doesn’t matter: Everyone blows right through going…
Letters
CEI Joins NTU-Led Coalition Warns of BBB’s Impact on Drug Competition
Dear Senators and Representatives: On behalf of the undersigned organizations — taxpayer, consumer, and free market advocates from across the country — we write with…
City Journal
All for Show
New York City mayor Bill de Blasio will end his tenure at midnight, December 31, 2021, but he seems intent on inflicting one last insult…
National Review
Biden’s Travel Restrictions Don’t Follow the Science
Joe Biden never tires of saying his COVID-19 policies follow “the science.” He recently pontificated that he would battle the emerging Omicron coronavirus variant “with…
Letters
Coalition Letter to OIRA Re: Request for OIRA to Resolve Interagency Disagreement Concerning IQA Implementation About Medical Marijuana
The Competitive Enterprise Institute (CEI) requests that OIRA resolve a dispute between two different agencies concerning responsibility for ensuring compliance with the Information Quality Act.